BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36762437)

  • 1. Cerebral Small Vessel Disease Progression Increases Risk of Incident Parkinsonism.
    Jacob MA; Cai M; Bergkamp M; Darweesh SKL; Gelissen LMY; Marques J; Norris DG; Duering M; Esselink RAJ; Tuladhar AM; de Leeuw FE
    Ann Neurol; 2023 Jun; 93(6):1130-1141. PubMed ID: 36762437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebral small vessel disease and incident parkinsonism: The RUN DMC study.
    van der Holst HM; van Uden IW; Tuladhar AM; de Laat KF; van Norden AG; Norris DG; van Dijk EJ; Esselink RA; Platel B; de Leeuw FE
    Neurology; 2015 Nov; 85(18):1569-77. PubMed ID: 26446068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain atrophy and strategic lesion location increases risk of parkinsonism in cerebral small vessel disease.
    Bergkamp MI; Tuladhar AM; van der Holst HM; van Leijsen EMC; Ghafoorian M; van Uden IWM; van Dijk EJ; Norris DG; Platel B; Esselink RAJ; Leeuw FE
    Parkinsonism Relat Disord; 2019 Apr; 61():94-100. PubMed ID: 30448096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral Small Vessel Disease Progression and the Risk of Dementia: A 14-Year Follow-Up Study.
    Jacob MA; Cai M; van de Donk V; Bergkamp M; Marques J; Norris DG; Kessels RPC; Claassen JAHR; Duering M; Tuladhar AM; Leeuw FE
    Am J Psychiatry; 2023 Jul; 180(7):508-518. PubMed ID: 37073486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants and Temporal Dynamics of Cerebral Small Vessel Disease: 14-Year Follow-Up.
    Cai M; Jacob MA; van Loenen MR; Bergkamp M; Marques J; Norris DG; Duering M; Tuladhar AM; de Leeuw FE
    Stroke; 2022 Sep; 53(9):2789-2798. PubMed ID: 35506383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural Network Efficiency Predicts Conversion to Incident Parkinsonism in Patients With Cerebral Small Vessel Disease.
    Cai M; Jacob MA; Marques J; Norris DG; Duering M; Esselink RAJ; Zhang Y; de Leeuw FE; Tuladhar AM
    J Gerontol A Biol Sci Med Sci; 2024 Jan; 79(1):. PubMed ID: 37527837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of Nursing Home Admission in Cerebral Small Vessel Disease.
    Bergkamp MI; Wissink JGJ; van Leijsen EMC; Ghafoorian M; Norris DG; van Dijk EJ; Platel B; Tuladhar AM; de Leeuw FE
    Stroke; 2018 Nov; 49(11):2659-2665. PubMed ID: 30355195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Causes and consequences of cerebral small vessel disease. The RUN DMC study: a prospective cohort study. Study rationale and protocol.
    van Norden AG; de Laat KF; Gons RA; van Uden IW; van Dijk EJ; van Oudheusden LJ; Esselink RA; Bloem BR; van Engelen BG; Zwarts MJ; Tendolkar I; Olde-Rikkert MG; van der Vlugt MJ; Zwiers MP; Norris DG; de Leeuw FE
    BMC Neurol; 2011 Feb; 11():29. PubMed ID: 21356112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk Factors for and Clinical Relevance of Incident and Progression of Cerebral Small Vessel Disease Markers in an Asian Memory Clinic Population.
    Gyanwali B; Shaik MA; Tan BY; Venketasubramanian N; Chen C; Hilal S
    J Alzheimers Dis; 2019; 67(4):1209-1219. PubMed ID: 30714960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spatial Relation Between White Matter Hyperintensities and Incident Lacunes of Presumed Vascular Origin: A 14-Year Follow-Up Study.
    Yi F; Cai M; Jacob MA; Marques J; Norris DG; Duering M; Tuladhar AM; de Leeuw FE
    Stroke; 2022 Dec; 53(12):3688-3695. PubMed ID: 36189679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma Aβ (Amyloid-β) Levels and Severity and Progression of Small Vessel Disease.
    van Leijsen EMC; Kuiperij HB; Kersten I; Bergkamp MI; van Uden IWM; Vanderstichele H; Stoops E; Claassen JAHR; van Dijk EJ; de Leeuw FE; Verbeek MM
    Stroke; 2018 Apr; 49(4):884-890. PubMed ID: 29540613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonlinear temporal dynamics of cerebral small vessel disease: The RUN DMC study.
    van Leijsen EMC; van Uden IWM; Ghafoorian M; Bergkamp MI; Lohner V; Kooijmans ECM; van der Holst HM; Tuladhar AM; Norris DG; van Dijk EJ; Rutten-Jacobs LCA; Platel B; Klijn CJM; de Leeuw FE
    Neurology; 2017 Oct; 89(15):1569-1577. PubMed ID: 28878046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between cerebral small vessel diseases and mild parkinsonian signs in the elderly with vascular risk factors.
    Hatate J; Miwa K; Matsumoto M; Sasaki T; Yagita Y; Sakaguchi M; Kitagawa K; Mochizuki H
    Parkinsonism Relat Disord; 2016 May; 26():29-34. PubMed ID: 26949060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Large Perivascular Spaces Visible on Magnetic Resonance Imaging, Cerebral Small Vessel Disease Progression, and Risk of Dementia: The Age, Gene/Environment Susceptibility-Reykjavik Study.
    Ding J; Sigurðsson S; Jónsson PV; Eiriksdottir G; Charidimou A; Lopez OL; van Buchem MA; Guðnason V; Launer LJ
    JAMA Neurol; 2017 Sep; 74(9):1105-1112. PubMed ID: 28715552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors Associated With 8-Year Mortality in Older Patients With Cerebral Small Vessel Disease: The Radboud University Nijmegen Diffusion Tensor and Magnetic Resonance Cohort (RUN DMC) Study.
    van der Holst HM; van Uden IW; Tuladhar AM; de Laat KF; van Norden AG; Norris DG; van Dijk EJ; Rutten-Jacobs LC; de Leeuw FE
    JAMA Neurol; 2016 Apr; 73(4):402-9. PubMed ID: 26831360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progression of small vessel disease correlates with cortical thinning in Parkinson's disease.
    Foo H; Mak E; Yong TT; Wen MC; Chander RJ; Au WL; Tan L; Kandiah N
    Parkinsonism Relat Disord; 2016 Oct; 31():34-40. PubMed ID: 27397577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Term Longitudinal Course of Cognitive and Motor Symptoms in Patients With Cerebral Small Vessel Disease.
    Bergkamp MI; Jacob MA; Cai M; Claassen JA; Kessels RPC; Esselink R; Tuladhar AM; De Leeuw FE
    Neurology; 2024 Mar; 102(5):e209148. PubMed ID: 38382000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropsychiatric Correlates of Small Vessel Disease Progression in Incident Cognitive Decline: Independent and Interactive Effects.
    Kan CN; Gyanwali B; Hilal S; Ng KP; Venketasubramanian N; Chen CL; Xu X
    J Alzheimers Dis; 2020; 73(3):1053-1062. PubMed ID: 31884482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum Neurofilament Light Chain Is Associated with Incident Lacunes in Progressive Cerebral Small Vessel Disease.
    Peters N; van Leijsen E; Tuladhar AM; Barro C; Konieczny MJ; Ewers M; Lyrer P; Engelter ST; Kuhle J; Duering M; de Leeuw FE
    J Stroke; 2020 Sep; 22(3):369-376. PubMed ID: 33053952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-Specific Associations of Renal Impairment With Magnetic Resonance Imaging Markers of Cerebral Small Vessel Disease in Transient Ischemic Attack and Stroke.
    Liu B; Lau KK; Li L; Lovelock C; Liu M; Kuker W; Rothwell PM
    Stroke; 2018 Apr; 49(4):899-904. PubMed ID: 29523652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.